{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:57:48Z","timestamp":1783133868482,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015738","name":"Mary and Georg C Ehrnrooth Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2017218"],"award-info":[{"award-number":["TYH2017218"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","award":["TYH2020315"],"award-info":[{"award-number":["TYH2020315"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013511","name":"Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011905","name":"Evald and Hilda Nissi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015822","name":"Fondazione Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006383","name":"Sy\u00f6p\u00e4j\u00e4rjest\u00f6t","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013510","name":"Eye and Tissue Bank Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"\u00d6gonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ajo.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T21:03:32Z","timestamp":1667250212000},"page":"258-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-4269","authenticated-orcid":false,"given":"Elina S.","family":"Rantala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0216-727X","authenticated-orcid":false,"given":"Raffaele","family":"Parrozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0139-4596","authenticated-orcid":false,"given":"Micaela M.","family":"Hernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9191-9124","authenticated-orcid":false,"given":"Vanna","family":"Chiarion-Sileni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1198-4394","authenticated-orcid":false,"given":"Tero T.","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-6233","authenticated-orcid":false,"given":"Edoardo","family":"Midena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2022.10.017_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","article-title":"Survival of patients with metastases from uveal melanoma","volume":"98","author":"Gragoudas","year":"1991","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2022.10.017_bib0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/CMR.0000000000000575","article-title":"Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis","volume":"29","author":"Rantala","year":"2019","journal-title":"Melanoma Res"},{"issue":"8","key":"10.1016\/j.ajo.2022.10.017_bib0003","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/annonc\/mdz176","article-title":"Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an International Rare Cancers Initiative (IRCI) ocular melanoma study","volume":"30","author":"Khoja","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajo.2022.10.017_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101041","article-title":"Metastatic uveal melanoma: the final frontier","volume":"90","author":"Rantala","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2022.10.017_bib0005","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2022.10.017_bib0006","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/CMR.0000000000000728","article-title":"Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma","volume":"31","author":"Rantala","year":"2021","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.ajo.2022.10.017_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/0284186X.2020.1817978","article-title":"Metastatic uveal melanoma managed with best supportive care","volume":"60","author":"Rantala","year":"2021","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ajo.2022.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4143\/crt.2017.171","article-title":"Prognostic factors and decision tree for long-term survival in metastatic uveal melanoma","volume":"50","author":"Lorenzo","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ajo.2022.10.017_bib0009","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archopht.122.2.285","article-title":"Long-term survival in a patient with uveal melanoma and liver metastasis","volume":"122","author":"Duh","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"31","key":"10.1016\/j.ajo.2022.10.017_bib0010","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","article-title":"Variates of survival in metastatic uveal melanoma","volume":"23","author":"Rietschel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2022.10.017_bib0011","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874364101206010049","article-title":"Long-term survivors with metastatic uveal melanoma","volume":"6","author":"Buzzacco","year":"2012","journal-title":"Open Ophthalmol J"},{"issue":"6","key":"10.1016\/j.ajo.2022.10.017_bib0012","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00262-021-03090-4","article-title":"Clinical determinants of long-term survival in metastatic uveal melanoma","volume":"71","author":"Koch","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajo.2022.10.017_bib0013","series-title":"AJCC Cancer Staging Manual","first-page":"813","article-title":"Uveal melanoma","author":"Kivel\u00e4","year":"2017"},{"key":"10.1016\/j.ajo.2022.10.017_bib0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ajo.2020.03.049","article-title":"Hepatic ultrasonography compared with computed tomography and magnetic resonance imaging at diagnosis of metastatic uveal melanoma","volume":"216","author":"Rantala","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2022.10.017_bib0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ajo.2022.10.017_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120181","article-title":"Development and external validation of a prognostic nomogram for metastatic uveal melanoma","volume":"10","author":"Valpione","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2022.10.017_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1385-7258(52)50043-X","article-title":"The asymptotic normality and consistency of Kendall's test against trend, when ties are present in one ranking","volume":"14","author":"Terpstra","year":"1952","journal-title":"Indagationes Mathematicae"},{"issue":"1\/2","key":"10.1016\/j.ajo.2022.10.017_bib0018","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2307\/2333011","article-title":"A distribution-free k-sample test against ordered alternatives","volume":"41","author":"Jonckheere","year":"1954","journal-title":"Biometrika"},{"issue":"5","key":"10.1016\/j.ajo.2022.10.017_bib0019","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2022.10.017_bib0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3390\/cancers11060863","article-title":"Development of a prognostic nomogram for liver metastasis of uveal melanoma patients selected by liver MRI","volume":"11","author":"Mariani","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"15 suppl","key":"10.1016\/j.ajo.2022.10.017_bib0021","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1200\/JCO.2021.39.15_suppl.9535","article-title":"Clinical characteristics of SF3B1 mutant (mut) uveal melanoma (UM) and response to immune checkpoint inhibition (ICI)","volume":"39","author":"Grimes","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ajo.2022.10.017_bib0022","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11113","article-title":"A prognostic model and staging for metastatic uveal melanoma","volume":"97","author":"Eskelin","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ajo.2022.10.017_bib0023","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1158\/1535-7163.MCT-19-0098","article-title":"Genomic profiling of metastatic uveal melanoma and clinical results of a phase I study of the protein kinase C inhibitor AEB071","volume":"19","author":"Piperno-Neumann","year":"2020","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"10.1016\/j.ajo.2022.10.017_bib0024","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ajo.2022.10.017_bib0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccell.2017.12.013","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"33","author":"Robertson","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajo.2022.10.017_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10.1016\/j.ajo.2022.10.017_bib0027","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/jamaophthalmol.2018.2986","article-title":"Association of uveal melanoma metastatic rate with stochastic mutation rate and type of mutation","volume":"136","author":"Szalai","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2022.10.017_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"issue":"16","key":"10.1016\/j.ajo.2022.10.017_bib0029","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/sim.1047","article-title":"A solution to the problem of separation in logistic regression","volume":"21","author":"Heinze","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ajo.2022.10.017_bib0030","series-title":"Applied Logistic Regression","first-page":"269","author":"Hosmer","year":"2013"},{"issue":"7","key":"10.1016\/j.ajo.2022.10.017_bib0031","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jamaophthalmol.2016.0903","article-title":"Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes","volume":"134","author":"Decatur","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2022.10.017_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ajcp\/aqac019","article-title":"Genomic profiling of metastatic uveal melanoma shows frequent coexisting BAP1 or SF3B1 and GNAQ\/GNA11 mutations and correlation with prognosis","volume":"158","author":"Isaacson","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ajo.2022.10.017_bib0033","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/cancers14030846","article-title":"Identification of early-onset metastasis in SF3B1 mutated uveal melanoma","volume":"14","author":"Drabarek","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ajo.2022.10.017_bib0034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10384-019-00656-9","article-title":"Clinical predictors of survival in metastatic uveal melanoma","volume":"63","author":"Lorenzo","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2022.10.017_bib0035","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.ejso.2009.02.016","article-title":"Surgical management of liver metastases from uveal melanoma: 16 years\u2019 experience at the Institut Curie","volume":"35","author":"Mariani","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ajo.2022.10.017_bib0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2016.06.002","article-title":"Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European Ophthalmic Oncology Group","volume":"168","author":"Kivel\u00e4","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2022.10.017_bib0037","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/cancers11071007","article-title":"Metastatic uveal melanoma: treatment strategies and survival-results from the Dutch melanoma treatment registry","volume":"11","author":"Jochems","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ajo.2022.10.017_bib0038","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","article-title":"Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23","volume":"22","author":"Diener-West","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajo.2022.10.017_bib0039","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/eye.1998.245","article-title":"Predictive power of screening tests for metastasis in uveal melanoma","volume":"12","author":"Hicks","year":"1998","journal-title":"Eye"},{"issue":"12","key":"10.1016\/j.ajo.2022.10.017_bib0040","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/archophthalmol.2011.263","article-title":"Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma","volume":"129","author":"Patel","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2022.10.017_bib0041","series-title":"Interpretation of Diagnostic Tests","first-page":"34","author":"Wallach","year":"2007"},{"issue":"1","key":"10.1016\/j.ajo.2022.10.017_bib0042","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41525-021-00233-5","article-title":"Multiregional genetic evolution of metastatic uveal melanoma","volume":"6","author":"Rodriguez","year":"2021","journal-title":"NPJ Genom Med"},{"issue":"12","key":"10.1016\/j.ajo.2022.10.017_bib0043","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S1470-2045(16)30578-2","article-title":"Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials","volume":"17","author":"Long","year":"2016","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ajo.2022.10.017_bib0044","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.ejso.2019.06.036","article-title":"Iterative treatment with surgery and radiofrequency ablation of uveal melanoma liver metastasis: retrospective analysis of a series of very long-term survivors","volume":"45","author":"Servois","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ajo.2022.10.017_bib0045","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","article-title":"Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors","volume":"9","author":"Rodrigues","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajo.2022.10.017_bib0046","unstructured":"United Nations Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, Online Edition. Rev 1. https:\/\/www.un.org\/development\/desa\/pd\/news\/world-population-prospects-2019-0."}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422004020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939422004020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:13:33Z","timestamp":1777385613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939422004020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S0002939422004020"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2022.10.017","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}